From concept to care: Realizing the potential of diagnostic integration for communities
In the wake of a 2025 shift in global health financing, the conversation has moved from "vertical" disease silos to integrated, person-centered health systems. This booth talk, co-hosted by FHI 360 and Roche Diagnostics, will explore what operationalizing this shift looks like – not just as a policy goal, but as a practical reality across the patient journey. The session will move beyond the theory of integration to showcase how existing HIV laboratory infrastructure is being "unlocked" to provide a multi-pathogen diagnostic menu, including TB, HPV, and hepatitis, while improving the patient experience from the community to the clinic.
Speakers: FHI 360 (Deb Carpenter & Andy Eyo)
Date: 28th July Time: 10:00 AM
One lab, many diseases: Reimagining HIV diagnostics into resilient, integrated National Lab Systems
For two decades, HIV diagnostics have been a global health success story: built rapidly, funded generously, and scaled to reach millions. As countries push toward the final stretch of global HIV targets, diagnostic systems built for a single disease are increasingly a liability rather than an asset. This talk explores how HIV diagnostics can evolve from siloed, vertically funded programs into integrated components of national laboratory networks by sharing platforms, workforce, specimen referral systems, and data infrastructure across HIV, TB, hepatitis, new epidemics, and other disease areas. Drawing on lessons learnt, we'll examine what it takes to achieve HIV goals and build more efficient, sustainable, and resilient diagnostic systems for the diseases of tomorrow.
Speaker: Lara Vojnov
Date: 28th July Time: 11:30 AM
Health systems through the lens of diagnostics, integration, and lived experience
As African healthcare systems navigate funding transitions, workforce pressures, and increasing demand for integrated care, fragmented disease-specific diagnostic models are becoming increasingly unsustainable. This session will explore how integrated and patient-centered diagnostic systems can strengthen HIV, TB, STI, cervical cancer, antimicrobial resistance, and non-communicable disease responses while reducing duplication, inefficiencies, and missed opportunities for care. The discussion will focus on practical approaches for building coordinated, sustainable, and people-centered laboratory networks.
Speaker: Cynthia Kasonde
Date: 28th July Time: 1:00 PM
Bringing treatment monitoring to meet the clinical needs in the TLD era, and beyond
This session, moderated by Sergio Carmona with panelists Lara Vojnov and Francois Venter, explores the need to re-envision HIV treatment monitoring in the wake of successful TLD scale-up. Given the high viral suppression rates and improved tolerability of TLD compared to older regimens, the panel discusses whether current monitoring algorithms should be adapted to better match differentiated service delivery models. The session aims to identify strategies that maximize clinical benefits and efficiencies while focusing resources on those most in need.
Speakers: Rupa Patel & Francois Venter
Date: 28th July Time: 2:30 PM
Translating innovation into impact: Lessons from PrEP product Introduction
This presentation focuses on transforming biomedical HIV prevention innovations into viable, real-world choices by bridging the gap between product development and equitable delivery. Drawing on lessons from earlier PrEP rollouts, it highlights the critical role of user preference, de-medicalized delivery models, and collaborative structural planning to turn next-generation technologies—like long-acting injectables and rings—into impactful, scalable public health solutions.
Speaker: Mitchell Warren
Date: 28th July Time: 4:00 PM
